Your Cart is Empty

Crowdfunding for the MCAS, EDS & POTS Documentary

We are currently holding a crowdfunding effort for a documentary on Mast Cell Activation Syndrome (MCAS), Ehlers-Danlos syndrome (EDS), and Postural Orthostatic Tachycardia Syndrome (POTS). These conditions could affect up to 17% of the population. They are challenging to diagnose and treat. Often, patients have spent years suffering after seeking medical help from numerous doctors and trying just about every medication, supplement, diet, etc., only to feel no better.

The project involves producing a 60-minute and three 30-minute documentaries, each dedicated to one of the three conditions, and an unrestricted free educational online library for doctors and patients. Our Medical Advisor,  Dr. Leonard Weinstock, is the project lead.

You can sponsor a brick for $10 or have multiple bricks in a block. We can add your name on your brick/s or you can choose not to be named by ticking the privacy box. 

All donations are greatly appreciated and go towards the documentary, creating awareness and understanding of these conditions. The outcome of this documentary could be an excellent chance for patients to reach out to you.

We aim to have the documentary shown on Netflix,  filming starts in November 2023.

Donations over $500 are tax deducible in the US see here

 The Documentary is being produced for the LDN Research Trust.


* indicates required
Which Mailing List Would you like to join? *

LDN Research Trust will use the information you provide on this form to enable us to email you to provide, newsletters, events, announcements and marketing materials. Please tick the email boxes below.

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at contact@ldnresearchtrust.org. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.